Experimental drug offered to fight wasting in advanced pancreatic cancer
Symptom relief
NO_LONGER_AVAILABLE
This program provided access to an investigational drug called mifomelatide for adults with advanced pancreatic cancer who were experiencing severe, unintentional weight loss (cachexia) and had no other good treatment options for it. Eligible patients received daily injections of…
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated Apr 02, 2026 01:11 UTC